“The Economic Impact Associated With Cerebrovascular Events Related to Non-Valvular Atrial Fibrillation (NVAF) in Italy: The Role of Apixaban”. 2014. Farmeconomia. Health Economics and Therapeutic Pathways 15 (1S): 3-4. https://doi.org/10.7175/fe.v15i1s.972.